• ქართული
  • English
  • Novartis raises 2019 guidance, helped by Sandoz generics unit

    Novartis lifted full-year sales and profit targets on Thursday, helped by innovative medicine sales and as the Swiss drugmaker’s Sandoz generics unit saw rising international demand for its biosimilar copies of blockbuster drugs made by rivals.

    Market Quotes by TradingView